Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Schizophrenia

  Free Subscription


Articles published in J Clin Psychopharmacol

Retrieve available abstracts of 91 articles:
HTML format



Single Articles


    June 2022
  1. KOGURE M, Kanahara N, Kimura M, Hanaoka S, et al
    Long-Term Treatment With Long-Acting Injectable Antipsychotic in Schizophrenia Patients With and Without Dopamine Supersensitivity Psychosis: A 6-Year Retrospective Comparative Study.
    J Clin Psychopharmacol. 2022 Jun 17. pii: 00004714-990000000-00026.
    PubMed     Abstract available


  2. CHIU CC, Lin C, Chen WY, Chen CR, et al
    Therapeutic Drug Monitoring of Paliperidone in Patients With Schizophrenia in Taiwan.
    J Clin Psychopharmacol. 2022 Jun 14. pii: 00004714-990000000-00023.
    PubMed     Abstract available


  3. WANG D, Wei N, Hu F, Li J, et al
    Paliperidone Extended Release Versus Olanzapine in Treatment-Resistant Schizophrenia: A Randomized, Double-Blind, Multicenter Study.
    J Clin Psychopharmacol. 2022 Jun 10. pii: 00004714-990000000-00019.
    PubMed     Abstract available


    May 2022
  4. GALLAGHER KE, Funaro MC, Woods SW
    Prescription Stimulants and the Risk of Psychosis: A Systematic Review of Observational Studies.
    J Clin Psychopharmacol. 2022;42:308-314.
    PubMed     Abstract available


    March 2022
  5. YEE CS, Bahji A, Lolich M, Vazquez GH, et al
    Comparative Efficacy and Tolerability of Antipsychotics for Juvenile Psychotic Disorders: A Systematic Review and Network Meta-Analysis.
    J Clin Psychopharmacol. 2022;42:198-208.
    PubMed     Abstract available


  6. FRANKENBURG FR, Malvesti S
    Paliperidone and Edema.
    J Clin Psychopharmacol. 2022;42:225-226.
    PubMed    


    February 2022
  7. TAKAKI M, Yada Y, Sakamoto S, Fujiwara M, et al
    A Decrease of Neutrophils After COVID-19 Vaccination in a Treatment-Resistant Patient With Schizophrenia Taking Clozapine.
    J Clin Psychopharmacol. 2022 Feb 10. pii: 00004714-900000000-98207.
    PubMed    


    January 2022
  8. WANG XY, Chan HY, Lin CH
    Time to Rehospitalization for Different Oral Risperidone Dosing Frequencies in Patients With Schizophrenia: A 17-Year Retrospective Cohort Study.
    J Clin Psychopharmacol. 2022 Jan 6. pii: 00004714-900000000-98219.
    PubMed     Abstract available


  9. CINTRON PASTRANA MA, Quintana Aviles E
    Treatment of Refractory Schizophrenia With Clozapine in a Patient With Wolff-Parkinson-White Syndrome.
    J Clin Psychopharmacol. 2022;42:95-96.
    PubMed    


  10. HE L, Yu Y, Zhang L, He S, et al
    A Real-World Study of Risk Factors for QTc Prolongation in Schizophrenia Patients Receiving Atypical Antipsychotics.
    J Clin Psychopharmacol. 2022;42:71-74.
    PubMed     Abstract available


  11. SMITH RL, Wollmann BM, Kylleso L, Tran TTA, et al
    Effect of Valproic Acid on the Metabolic Spectrum of Clozapine in Patients With Schizophrenia.
    J Clin Psychopharmacol. 2022;42:43-50.
    PubMed     Abstract available


  12. STROMME MF, Mellesdal LS, Bartz-Johannesen CA, Kroken RA, et al
    Use of Benzodiazepines and Antipsychotic Drugs Are Inversely Associated With Acute Readmission Risk in Schizophrenia.
    J Clin Psychopharmacol. 2022;42:37-42.
    PubMed     Abstract available


  13. GARRIGA M, Mallorqui A, Bernad S, Ruiz-Cortes V, et al
    Antipsychotic-Associated Weight Gain and Clinical Improvement Under Clozapine Treatment.
    J Clin Psychopharmacol. 2022;42:75-80.
    PubMed     Abstract available


  14. BONNET U, Knierim U, Ronge R, Jahn J, et al
    Late-Onset Polyserositis Emerging During Long-Term Clozapine Treatment and Persisting After Clozapine Discontinuation: Is Clozapine Really Innocent?
    J Clin Psychopharmacol. 2022;42:106-107.
    PubMed    


  15. ERDOGAN A, Ilhan F
    Risperidone-Associated Acute Laryngeal Dystonia: A Case Report.
    J Clin Psychopharmacol. 2022;42:98-99.
    PubMed    


    November 2021
  16. MAURI MC, Franco G, Minutillo A, Paletta S, et al
    The Switch From Paliperidone Long-Acting Injectable 1- to 3-Monthly: Clinical Pharmacokinetic Evaluation in Patients With Schizophrenia (Preliminary Data).
    J Clin Psychopharmacol. 2021 Nov 24. pii: 00004714-900000000-98229.
    PubMed     Abstract available


  17. RUDA D, Jensen KG, Decara MS, Klauber DG, et al
    CYP2D6 Genotyping and Antipsychotic-Associated Extrapyramidal Adverse Effects in a Randomized Trial of Aripiprazole Versus Quetiapine Extended Release in Children and Adolescents, Aged 12-17 Years, With First Episode Psychosis.
    J Clin Psychopharmacol. 2021;41:667-672.
    PubMed     Abstract available


  18. WEIZMAN S, Shelef A, Bloemhof Bris E, Stryjer R, et al
    A Double-Blind, Placebo-Controlled Trial of Bupropion Add-on to Olanzapine or Risperidone in Overweight Individuals With Schizophrenia.
    J Clin Psychopharmacol. 2021;41:629-631.
    PubMed     Abstract available


  19. COMAI S, Fuamba Y, Rivolta MC, Gobbi G, et al
    Lifetime Cannabis Use Disorder Is Not Associated With Lifetime Impulsive Behavior and Severe Violence in Patients With Schizophrenia Spectrum Disorders From a High-Security Hospital.
    J Clin Psychopharmacol. 2021;41:623-628.
    PubMed     Abstract available


  20. MAKHLOUF AT, Van Alphen MU, Manzano GS, Freudenreich O, et al
    A Seizure After COVID-19 Vaccination in a Patient on Clozapine.
    J Clin Psychopharmacol. 2021;41:689-690.
    PubMed    


  21. CELLINI L, De Donatis D, Mercolini L, Panariello F, et al
    Switch to 3-Month Long-Acting Injectable Paliperidone May Decrease Plasma Levels: A Case Series.
    J Clin Psychopharmacol. 2021;41:694-696.
    PubMed    


  22. OKEYA K, Misawa F, Fujii Y, Takeuchi H, et al
    Olanzapine Reduction From High Dose to Standard Dose: A Retrospective Chart Review.
    J Clin Psychopharmacol. 2021;41:676-680.
    PubMed     Abstract available


  23. SELCUK M
    Tardive Myoclonus Responsive to Clozapine Misdiagnosed as Restless Leg Syndrome: A Case Report.
    J Clin Psychopharmacol. 2021;41:692-694.
    PubMed    


    September 2021
  24. SRIFUENGFUNG M, Sukakul T, Pummangura C, Srifuengfung S, et al
    Oral Ulcers as an Unpredictable Adverse Reaction to Quetiapine Use in a Patient With Schizophrenia.
    J Clin Psychopharmacol. 2021 Sep 9. pii: 00004714-900000000-98247.
    PubMed    


  25. MASHIMA Y, Uchida H, Kinoshita S, Arita Y, et al
    Camptocormia Secondary to Antipsychotic-Associated Dystonia of the Rectus Abdominis Muscles Detected by Abdominal Computed Tomography: A Case Report.
    J Clin Psychopharmacol. 2021;41:608-610.
    PubMed    


  26. CUOMO A, Chioccioli M, Cattaneo CI, Magnani PA, et al
    Effectiveness of Intramuscular Chlorpromazine for Rapid Treatment of Psychomotor Agitation: A Naturalistic, Retrospective, and Observational Study.
    J Clin Psychopharmacol. 2021;41:613-614.
    PubMed    


    August 2021
  27. PEITL V, Badzim VA, Sisko Markos I, Rendulic A, et al
    Improvements of Frontotemporal Cerebral Blood Flow and Cognitive Functioning in Patients With First Episode of Schizophrenia Treated With Long-Acting Aripiprazole.
    J Clin Psychopharmacol. 2021 Aug 26. pii: 00004714-900000000-98248.
    PubMed     Abstract available


  28. OGAWA T, Tachikawa H, Shiratori Y, Sodeyama N, et al
    Use of Blonanserin Transdermal Patch in Home Treatment of Schizophrenia: A Case Study.
    J Clin Psychopharmacol. 2021 Aug 23. pii: 00004714-900000000-98251.
    PubMed    


  29. LIM M, Li Z, Xie H, Tan BL, et al
    The Effect of Therapeutic Alliance on Attitudes Toward Psychiatric Medications in Schizophrenia.
    J Clin Psychopharmacol. 2021 Aug 13. pii: 00004714-900000000-98260.
    PubMed     Abstract available


    July 2021

  30. Association of Aripiprazole With Reduced Hippocampal Atrophy During Maintenance Treatment of First-Episode Schizophrenia: Erratum.
    J Clin Psychopharmacol. 2021;41:507.
    PubMed    


  31. AFTAB R, Pereira M, Hewitt J, Whale R, et al
    Effectiveness and Predictors of Discontinuation of Aripiprazole Long-acting Injection: A 12-Month Naturalistic Cohort Study.
    J Clin Psychopharmacol. 2021;41:478-483.
    PubMed     Abstract available


  32. GLICK ID, Cerfolio NE, Kamis D, Laurence M, et al
    Domestic Mass Shooters: The Association With Unmedicated and Untreated Psychiatric Illness.
    J Clin Psychopharmacol. 2021;41:366-369.
    PubMed     Abstract available


  33. SINKEVICIUTE I, Hugdahl K, Bartz-Johannessen C, Kroken RA, et al
    Differential Effectiveness of Atypical Antipsychotics on Hallucinations: A Pragmatic Randomized Controlled Trial.
    J Clin Psychopharmacol. 2021;41:389-396.
    PubMed     Abstract available


  34. SUHAS S, Manchegowda S, Venkatasubramanian G, Kumar V, et al
    Clozapine and Oral Contraceptives-Implications Beyond Pharmacokinetics: A Case Report.
    J Clin Psychopharmacol. 2021;41:487-490.
    PubMed    


    June 2021
  35. KOREKI A, Mori H, Nozaki S, Koizumi T, et al
    Risk of Nonalcoholic Fatty Liver Disease in Patients With Schizophrenia Treated With Antipsychotic Drugs: A Cross-sectional Study.
    J Clin Psychopharmacol. 2021 Jun 4. pii: 00004714-900000000-98299.
    PubMed     Abstract available


    May 2021
  36. SUHAS S, Shivani S, Singh GK, Venkatasubramanian G, et al
    Festina Lente: Betahistine for Clozapine-Associated Weight Gain: A Case Report.
    J Clin Psychopharmacol. 2021;41:332-333.
    PubMed    


  37. SUZUKI K, Castelli M, Komaroff M, Starling B, et al
    Pharmacokinetic Profile of the Asenapine Transdermal System (HP-3070).
    J Clin Psychopharmacol. 2021;41:286-294.
    PubMed     Abstract available


  38. MATHUR R, Singh J, Sood M
    A Case Report of Clozapine-Associated Stuttering and Amisulpride-Associated Stuttering and Seizure in an Adult on Concurrent Fluoxetine Therapy.
    J Clin Psychopharmacol. 2021;41:330-332.
    PubMed    


  39. TIRUPATI S, Gordon T
    Continuation of Treatment With Clozapine After an Episode of Neutropenia.
    J Clin Psychopharmacol. 2021;41:320-322.
    PubMed     Abstract available


    April 2021
  40. GUIMARAES TM, Guimaraes MRC, Oliveira IAF, Leoni RF, et al
    Mononitrate Isosorbide as an Adjunctive Therapy in Schizophrenia: A Randomized Controlled Crossover Trial.
    J Clin Psychopharmacol. 2021 Apr 14. pii: 00004714-900000000-98311.
    PubMed     Abstract available


  41. LINDENMAYER JP, Rizvi S
    Augmentation With Pimavanserin in Treatment Refractory Schizophrenia: Case Report.
    J Clin Psychopharmacol. 2021 Apr 13. pii: 00004714-900000000-98312.
    PubMed    


    March 2021
  42. AN H, Fan H, Chen S, Qi S, et al
    Effects of Dose, Age, Sex, Body Weight, and Smoking on Plasma Concentrations of Olanzapine and N-desmethyl Olanzapine in Inpatients With Schizophrenia.
    J Clin Psychopharmacol. 2021 Mar 31. pii: 00004714-900000000-98320.
    PubMed     Abstract available


  43. WANG J, Hart KL, Qi W, Ardekani BA, et al
    Association of Aripiprazole With Reduced Hippocampal Atrophy During Maintenance Treatment of First-Episode Schizophrenia.
    J Clin Psychopharmacol. 2021 Mar 31. pii: 00004714-900000000-98319.
    PubMed     Abstract available


  44. BUCHANAN RW, Kelly DL, Strauss GP, Gold JM, et al
    Combined Oxytocin and Cognitive Behavioral Social Skills Training for Social Function in People With Schizophrenia.
    J Clin Psychopharmacol. 2021 Mar 30. pii: 00004714-900000000-98321.
    PubMed     Abstract available


  45. BALDAQUI N, Anmella G, Gomez-Ramiro M, Guasp M, et al
    Thyrotoxic Psychosis Associated With Amiodarone.
    J Clin Psychopharmacol. 2021 Mar 12. pii: 00004714-900000000-98331.
    PubMed    


  46. LECLERC LD, Demers MF, Bardell A, Bilodeau I, et al
    A Chart Audit Study of Clozapine Utilization in Early Psychosis.
    J Clin Psychopharmacol. 2021 Mar 12. pii: 00004714-900000000-98327.
    PubMed     Abstract available


  47. IWATA Y, Aruga Y, Ohtsuki M, Inoue M, et al
    Successful Introduction of Paliperidone Palmitate for Pregnant Woman With Schizophrenia: Case Presentation and Literature Review.
    J Clin Psychopharmacol. 2021;41:210-212.
    PubMed    


  48. REHIMINI S, Goddard KG, Margolese HC
    Exceptionally High Clozapine-Associated Eosinophilia.
    J Clin Psychopharmacol. 2021;41:216-218.
    PubMed    


  49. GROVER S, Naskar C, Chakrabarti S
    Does the Starting of Clozapine Influence Coprescription of Other Medications?: A Study From India.
    J Clin Psychopharmacol. 2021;41:148-154.
    PubMed     Abstract available


  50. GRIFFIN JM, Woznica E, Gilotra NA, Nucifora FC Jr, et al
    Clozapine-Associated Myocarditis: A Protocol for Monitoring Upon Clozapine Initiation and Recommendations for How to Conduct a Clozapine Rechallenge.
    J Clin Psychopharmacol. 2021;41:180-185.
    PubMed     Abstract available


  51. YILDIZ MI, Karacam Dogan M, Mutlu E, Abdullayeva L, et al
    All in One: Clozapine-Associated Acute Pancreatitis With Multiple Organ Involvement.
    J Clin Psychopharmacol. 2021;41:214-216.
    PubMed    


  52. KHURRAM SK, Ames M, Muniz J
    Case Report: Valbenazine as a Treatment for Tardive Dyskinesia and Unexpected Antipsychotic Effects.
    J Clin Psychopharmacol. 2021;41:220-221.
    PubMed    


  53. MISAWA F, Fujii Y, Takeuchi H
    Can a 4-Month Tolerability Assessment With Paliperidone Palmitate 1-Monthly Prevent Neuroleptic Malignant Syndrome Associated With the 3-Monthly?: Analysis Based on a Spontaneous Reporting System Database in Japan.
    J Clin Psychopharmacol. 2021;41:206-207.
    PubMed    


  54. DANILEWITZ M, Rafizadeh R, Bousman CA
    Successful Clozapine Rechallenge After Suspected Clozapine-Associated Myocarditis: A Case Report.
    J Clin Psychopharmacol. 2021;41:218-220.
    PubMed    


    February 2021
  55. BENGTSSON J, Olsson E, Igelstrom H, Persson J, et al
    Ambulatory Heart Rate Variability in Schizophrenia or Depression: Impact of Anticholinergic Burden and Other Factors.
    J Clin Psychopharmacol. 2021 Feb 13. pii: 00004714-900000000-98342.
    PubMed     Abstract available


  56. ANDARI E, Massa NM, Fargotstein MD, Taylor NB, et al
    Effects of Oxytocin on Emotion Recognition in Schizophrenia: A Randomized Double-Blind Pilot Study.
    J Clin Psychopharmacol. 2021 Feb 13. pii: 00004714-900000000-98352.
    PubMed     Abstract available


  57. MIYAUCHI T
    Long-Term Improvement of Aggression in a Patient With Schizophrenia Using Allopurinol as an Adjuvant: A Case Report.
    J Clin Psychopharmacol. 2021 Feb 13. pii: 00004714-900000000-98348.
    PubMed    


  58. DE BEAUREPAIRE R
    Binge Eating Disorders in Antipsychotic-Treated Patients With Schizophrenia: Prevalence, Antipsychotic Specificities, and Changes Over Time.
    J Clin Psychopharmacol. 2021 Feb 13. pii: 00004714-900000000-98347.
    PubMed     Abstract available


  59. LEISING J, Barr AM, Procyshyn RM, Ainsworth NJ, et al
    High-Dose Fluvoxamine Augmentation to Clozapine in Treatment-Resistant Psychosis.
    J Clin Psychopharmacol. 2021 Feb 13. pii: 00004714-900000000-98344.
    PubMed     Abstract available


  60. KELLY DL, Kane MA, Fraser CM, Sayer MA, et al
    Prebiotic Treatment Increases Serum Butyrate in People With Schizophrenia: Results of an Open-Label Inpatient Pilot Clinical Trial.
    J Clin Psychopharmacol. 2021 Feb 11. pii: 00004714-900000000-98356.
    PubMed    


  61. BO Q, Xing X, Li T, Mao Z, et al
    Menstrual Dysfunction in Women With Schizophrenia During Risperidone Maintenance Treatment.
    J Clin Psychopharmacol. 2021 Feb 1. pii: 00004714-900000000-98361.
    PubMed     Abstract available


    January 2021
  62. PRIDMORE S, Naguy A, Moodliar-Rensburg S, Alamiri B, et al
    Advantageous Add-on Duloxetine to Aripiprazole-Responsive Early-Onset Schizophrenia.
    J Clin Psychopharmacol. 2021;41:91-92.
    PubMed    


  63. SUBEESH V, Maheswari E, Singh H, Neha R, et al
    Finding Early Improvement Threshold to Predict Response After 8 Weeks of Treatment Using Risperidone in First-Episode Psychosis.
    J Clin Psychopharmacol. 2021;41:58-61.
    PubMed     Abstract available


  64. MAGUIRE A, Mooney C, Flynn G, Ferguson Y, et al
    No Effect of Coenzyme Q10 on Cognitive Function, Psychological Symptoms, and Health-related Outcomes in Schizophrenia and Schizoaffective Disorder: Results of a Randomized, Placebo-Controlled Trial.
    J Clin Psychopharmacol. 2021;41:53-57.
    PubMed     Abstract available


  65. VERMA M, Grover S, Chakrabarti S
    Cost of the Illness of Treatment-Resistant Schizophrenia: A Mirror Image Study Comparing Clozapine With Other Antipsychotics.
    J Clin Psychopharmacol. 2021;41:36-44.
    PubMed     Abstract available


  66. HOSSEININASAB M, Zarghami M, Mazhari S, Salehifar E, et al
    Nanocurcumin as an Add-on to Antipsychotic Drugs for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study.
    J Clin Psychopharmacol. 2021;41:25-30.
    PubMed     Abstract available


  67. BLACKMAN G, Lisshammar JEL, Zafar R, Pollak TA, et al
    Clozapine Response in Schizophrenia and Hematological Changes.
    J Clin Psychopharmacol. 2021;41:19-24.
    PubMed     Abstract available


    November 2020
  68. LE MOIGNE A, Fava M, Csernansky J, Newcomer JW, et al
    Reanalysis of a Phase 3 Trial of a Monthly Extended-Release Risperidone Injection for the Treatment of Acute Schizophrenia.
    J Clin Psychopharmacol. 2020 Nov 16. doi: 10.1097/JCP.0000000000001319.
    PubMed    


  69. RUIZ DE PELLON SANTAMARIA A
    Psychosis Treatment During COVID-19 Pandemic and the Potential Role of Phenothiazines: A Call for Research Studies.
    J Clin Psychopharmacol. 2020;40:641-642.
    PubMed    


  70. DROSOS P, Bronnick K, Joa I, Johannessen JO, et al
    One-Year Outcome and Adherence to Pharmacological Guidelines in First-Episode Schizophrenia: Results From a Consecutive Cohort Study.
    J Clin Psychopharmacol. 2020;40:534-540.
    PubMed     Abstract available


    October 2020
  71. NGUYEN AS, Grossman-Kahn R, Wichser L
    Anticipatory Clozapine Dosing After Discharge From Inpatient Treatment for the Patient With Comorbid Schizophrenia and Tobacco Use.
    J Clin Psychopharmacol. 2020 Oct 14. doi: 10.1097/JCP.0000000000001294.
    PubMed    


    September 2020
  72. MEYER RE
    Thoughts About Schizophrenia 66 Years After Chlorpromazine.
    J Clin Psychopharmacol. 2020;40:436-438.
    PubMed    


  73. CHEN B, Wang C, Xu X, Lyu H, et al
    Risk of Prolonged Corrected QT Interval With Amisulpride Therapy for Renal Function Management in Patients With Schizophrenia.
    J Clin Psychopharmacol. 2020;40:482-486.
    PubMed     Abstract available


    August 2020
  74. VAHDANI B, Armani Kian A, Esmaeilzadeh A, Zenoozian S, et al
    Adjunctive Raloxifene and Isradipine Improve Cognitive Functioning in Patients With Schizophrenia: A Pilot Study.
    J Clin Psychopharmacol. 2020 Aug 11. doi: 10.1097/JCP.0000000000001274.
    PubMed     Abstract available


  75. BUCHANAN RW, Weiner E, Kelly DL, Gold JM, et al
    Anti-inflammatory Combination Therapy for the Treatment of Schizophrenia.
    J Clin Psychopharmacol. 2020 Aug 11. doi: 10.1097/JCP.0000000000001253.
    PubMed     Abstract available


    July 2020
  76. OHI K, Muto Y, Sugiyama S, Shioiri T, et al
    Safety and Efficacy in Randomized Controlled Trials of Second-Generation Antipsychotics Versus Placebo for Cognitive Impairments in Schizophrenia: A Meta-Analysis.
    J Clin Psychopharmacol. 2020 Jul 24. doi: 10.1097/JCP.0000000000001232.
    PubMed    


  77. KWON JS, Lee J, Kim E, Kim SW, et al
    A Prospective Study for Prediction of Psychotic Relapse Using the Korean Early Signs Scale in Patients With Schizophrenia.
    J Clin Psychopharmacol. 2020 Jul 21. doi: 10.1097/JCP.0000000000001263.
    PubMed     Abstract available


  78. MOGHIMI SARANI E, Memari E, Anushiravani A, Mowla A, et al
    Is Sitagliptin Effective for Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients? A Double-blind Placebo-controlled Clinical Trial.
    J Clin Psychopharmacol. 2020 Jul 21. doi: 10.1097/JCP.0000000000001259.
    PubMed     Abstract available


  79. DONDE C, Polosan M, Guzun R
    Pitolisant for Treating Narcolepsy Comorbid With Schizophrenia.
    J Clin Psychopharmacol. 2020 Jul 15. doi: 10.1097/JCP.0000000000001243.
    PubMed    


  80. BRUNO A, Zoccali RA, Troili GM, Scala L, et al
    Vortioxetine on Cognition in Schizophrenia: A Pilot Study.
    J Clin Psychopharmacol. 2020;40:381-385.
    PubMed     Abstract available


  81. ROJNIC KUZMAN M, Makaric P, Bosnjak Kuharic D, Kekin I, et al
    General Functioning in Patients With First-Episode Psychosis After the First 18 Months of Treatment.
    J Clin Psychopharmacol. 2020;40:366-372.
    PubMed     Abstract available


  82. LINDENMAYER JP, Glick ID, Talreja H, Underriner M, et al
    Persistent Barriers to the Use of Long-Acting Injectable Antipsychotics for the Treatment of Schizophrenia.
    J Clin Psychopharmacol. 2020;40:346-349.
    PubMed     Abstract available


  83. ZHENG W, Xiang YQ, Cai DB, Yang XH, et al
    Adjunctive Fluvoxamine for Schizophrenia: A Meta-analysis of Randomized Double-Blind, Placebo-Controlled Trials.
    J Clin Psychopharmacol. 2020;40:386-390.
    PubMed     Abstract available


  84. CAROFF SN, Leong SH, Roberts CB, Berkowitz RM, et al
    Correlates of the Abnormal Involuntary Movement Scale in Veterans With Tardive Dyskinesia.
    J Clin Psychopharmacol. 2020;40:373-380.
    PubMed     Abstract available


    May 2020
  85. YESILKAYA UH, Balcioglu YH
    Adjunct Aripiprazole for Obsessive-Compulsive Symptoms Associated With Second-Generation Antipsychotics in 2 Patients With Schizophrenia: Anti-obsessional Efficacy of Partial Agonism.
    J Clin Psychopharmacol. 2020 May 19. doi: 10.1097/JCP.0000000000001214.
    PubMed    


  86. BIRNBAUM R, Weinberger DR
    Special Article: Translational Science Update. Pharmacological Implications of Emerging Schizophrenia Genetics: Can the Bridge From 'Genomics' to 'Therapeutics' be Defined and Traversed?
    J Clin Psychopharmacol. 2020 May 18. doi: 10.1097/JCP.0000000000001215.
    PubMed     Abstract available


  87. FRIENDSHUH CR, Pocivavsek A, Demyonovich H, Rodriguez KM, et al
    The Effects of a Gluten-Free Diet on Immune Markers and Kynurenic Acid Pathway Metabolites in Patients With Schizophrenia Positive for Antigliadin Antibodies Immunoglobulin G.
    J Clin Psychopharmacol. 2020;40:317-319.
    PubMed    


  88. KUZIN M, Bochon B, Vagiaris E, Dammann G, et al
    Changes in Clozapine Bioavailability in a Percutaneous Endoscopic Gastrostomy-Fed Patient With Treatment-Resistant Schizophrenia.
    J Clin Psychopharmacol. 2020;40:306-308.
    PubMed    


  89. MELTZER HY, Share DB, Jayathilake K, Salomon RM, et al
    Lurasidone Improves Psychopathology and Cognition in Treatment-Resistant Schizophrenia.
    J Clin Psychopharmacol. 2020;40:240-249.
    PubMed     Abstract available


    January 2020
  90. SUGAI T, Suzuki Y, Yamazaki M, Sugawara N, et al
    Lower Prolactin Levels in Patients Treated With Aripiprazole Regardless of Antipsychotic Monopharmacy or Polypharmacy.
    J Clin Psychopharmacol. 2020;40:14-17.
    PubMed     Abstract available


  91. SMITH C, Gwynn N, Lindenmayer JP
    Pisa Syndrome and Aripiprazole.
    J Clin Psychopharmacol. 2020;40:99-101.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: